Werewolf Therapeutics (HOWL) Assets Average (2021 - 2026)

Werewolf Therapeutics (HOWL) has reported Assets Average for 6 consecutive years, with $41.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Assets Average fell 58.87% year-over-year to $41.1 million in Q2 2026; TTM through Jun 2026 was $41.1 million, a 58.87% decrease from a year earlier, with the FY2025 full-year figure at $98.2 million, down 34.94% from the prior year.
• Assets Average was $41.1 million for Q2 2026 at Werewolf Therapeutics, down from $63.7 million in the prior quarter.
• Over five years, Assets Average peaked at $190.2 million in Q2 2023 and troughed at $41.1 million in Q2 2026.
• A 5-year average of $139.5 million and a median of $166.0 million in 2022 frame the typical range for Assets Average.
• Across the five-year window, Assets Average jumped 85.05% in 2022 and slumped 58.87% in 2026, its largest moves.
• Over 5 years, Assets Average stood at $166.3 million in 2022, then gained by 5.58% to $175.6 million in 2023, then slipped by 23.99% to $133.5 million in 2024, then plunged by 44.18% to $74.5 million in 2025, then tumbled by 44.86% to $41.1 million in 2026.
• The last three Assets Average figures came in at $41.1 million (Q2 2026), $63.7 million (Q1 2026), and $74.5 million (Q4 2025), per Business Quant data.